These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18078271)

  • 21. Successful treatment with vemurafenib in BRAF V600K-positive cerebral melanoma metastasis.
    Forschner A; Niessner H; Bauer J; Bender B; Garbe C; Meier F
    JAMA Dermatol; 2013 May; 149(5):642-4. PubMed ID: 23677116
    [No Abstract]   [Full Text] [Related]  

  • 22. The use of systemic therapies for the treatment of brain metastases in metastatic melanoma: opportunities and unanswered questions.
    Murrell J; Board R
    Cancer Treat Rev; 2013 Dec; 39(8):833-8. PubMed ID: 23845462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ulcerated plaques in the pelvic region of an adult female.
    Barrick B; Matthys B; Fraga G
    Dermatol Online J; 2012 Oct; 18(10):7. PubMed ID: 23122014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant melanoma of the breast: N-isopropyl-p-(123) I-iodoamphetamine single photon emission computed tomography ((123) I-IMP SPECT) is useful for the detection of metastasis.
    Ito Y; Doi H; Tsuji H; Ishida-Yamamto A; Iizuka H
    J Dermatol; 2010 Sep; 37(9):849-51. PubMed ID: 20883378
    [No Abstract]   [Full Text] [Related]  

  • 25. [Ipilimumab-induced hypophysitis].
    Schleder S; Schreml S; Heiss P
    Rofo; 2013 Mar; 185(3):268-9. PubMed ID: 23154861
    [No Abstract]   [Full Text] [Related]  

  • 26. Vemurafenib as a neoadjuvant therapy in advanced melanoma: local tumour control, but no prevention of metastatic relapse.
    Tauber M; Pages C; La Selva R; Schneider P; Chardin J; Osio A; Mourah S; Culine S; Vercellino L; Bagot M; Lebbé C
    Eur J Dermatol; 2013; 23(5):702-3. PubMed ID: 24135270
    [No Abstract]   [Full Text] [Related]  

  • 27. Adrenal Incidentaloma: Nothing Is Ever as It Seems.
    Komarowska H; Bromińska B; Janicka-Jedyńska M; Ruchała M
    Am J Med; 2020 Sep; 133(9):1048-1050. PubMed ID: 32001227
    [No Abstract]   [Full Text] [Related]  

  • 28. Breast metastases from cutaneous malignant melanoma.
    Bassi F; Gatti G; Mauri E; Ballardini B; De Pas T; Luini A
    Breast; 2004 Dec; 13(6):533-5. PubMed ID: 15563866
    [No Abstract]   [Full Text] [Related]  

  • 29. Melanoma Brain Metastasis Pseudoprogression after Pembrolizumab Treatment.
    Cohen JV; Alomari AK; Vortmeyer AO; Jilaveanu LB; Goldberg SB; Mahajan A; Chiang VL; Kluger HM
    Cancer Immunol Res; 2016 Mar; 4(3):179-82. PubMed ID: 26701266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapy of brain metastases: current status.
    Greig NH
    Cancer Treat Rev; 1984 Jun; 11(2):157-86. PubMed ID: 6388835
    [No Abstract]   [Full Text] [Related]  

  • 31. [Malignant melanoma with special reference to gynecologic aspects].
    Krämer U; Schulte KW; Schürer NY; Schuppe HC
    Gynakologe; 1994 Oct; 27(5):321-8. PubMed ID: 7821864
    [No Abstract]   [Full Text] [Related]  

  • 32. Ipilimumab in melanoma patients with brain metastasis: a retro-spective multicentre evaluation of thirty-eight patients.
    Konstantinou MP; Dutriaux C; Gaudy-Marqueste C; Mortier L; Bedane C; Girard C; Thellier S; Jouary T; Grob JJ; Richard MA; Templier C; Sakji L; Guillot B; Paul C; Meyer N
    Acta Derm Venereol; 2014 Jan; 94(1):45-9. PubMed ID: 23824275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A view on the landscape of breast cancer brain metastases.
    Malani R
    CNS Oncol; 2020 Sep; 9(3):CNS59. PubMed ID: 32990026
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of brain metastases of malignant melanoma with temozolomide.
    Biasco G; Pantaleo MA; Casadei S
    N Engl J Med; 2001 Aug; 345(8):621-2. PubMed ID: 11529230
    [No Abstract]   [Full Text] [Related]  

  • 35. The antibacterial substance, taurolidine in the second/third-line treatment of very advanced stage IV melanoma including brain metastases: results of a phase 2, open-label study.
    Imhof L; Goldinger SM; Baumann K; Schad K; French LE; Röthlisberger P; Dummer R
    Melanoma Res; 2011 Feb; 21(1):80-3. PubMed ID: 21052029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Volumetric response to radiosurgery for brain metastasis varies by cell of origin.
    Iyer A; Harrison G; Kano H; Weiner GM; Luther N; Niranjan A; Flickinger JC; Lunsford LD; Kondziolka D
    J Neurosurg; 2014 Sep; 121(3):564-9. PubMed ID: 24878286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in therapy for melanoma brain metastases.
    Flanigan JC; Jilaveanu LB; Chiang VL; Kluger HM
    Clin Dermatol; 2013; 31(3):264-81. PubMed ID: 23608446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted and immunotherapeutic approaches in brain metastases.
    Ahluwalia MS; Winkler F
    Am Soc Clin Oncol Educ Book; 2015; ():67-74. PubMed ID: 25993144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer chemotherapy: its role in the treatment strategy of hematologic malignancies and solid tumors.
    Clarysse A; Kenis Y; Mathe G
    Recent Results Cancer Res; 1976; (53):1-552. PubMed ID: 189368
    [No Abstract]   [Full Text] [Related]  

  • 40. [Chemotherapy and targeted therapies in the management of brain metastases].
    Carpentier AF
    Rev Prat; 2014 May; 64(5):679-81. PubMed ID: 24923060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.